BRM Enterprise Portfolio

BRM Enterprise pursues hand-picked investment opportunities in Israel, which show viable business models and strong growth potential, in traditional industries such as telecommunication services, financial markets and real estate.

Degania Silicone*
Established in 1984, Degania Silicone is a manufacturing and development company, specializing in the fabrication of high quality silicone medical and technical products.
The company supplies CE-marked products to hospitals via distributors, and also offers OEM services, manufacturing products and components for the medical device industry.

www.degania-silicone.co.il

 

  Glycominds
Glycominds Ltd. holds extensive knowledge and experience in the field of glycomics, utilized for the discovery and development of unique glycan biomarkers which enable high-value medical diagnostics. Glycominds is developing and commercializing a new class of novel blood tests which allow physicians to detect cancer earlier, predict autoimmune disease progression and decide on therapy regimen.

www.glycominds.com

 
  Hydro Industries*
Hydro Industries focuses on the development and marketing of technologically advanced value-added consumer products.  The Company’s products are based on its Hydro-Pro system – a revolutionary water powered engine which converts water pressure into other forms of energy, such as propulsion. Hydro's automatic hose reel gained significant market share in the North American market by becoming the major automatic product in the category.

www.no-crank.com

 
  NanoCyte
Founded in November 2000, NanoCyte has developed an immediate active release topical delivery platform technology. NanoCyte is utilizing marine extracted micro-injectors, providing a GMP-grade topical formulation which penetrates the skin within a fraction of a second, and actively delivers the compound into the epidermal skin layer.

www.nano-cyte.com

 

 * Investment was made via IGI, a private equity fund now part of The BRM Group.
 


   
Home   About   Strategy   Team   Investments   Press   Contact Us   Terms of Use